LIXT Financials
Lixte Biotechnology Holdings Inc - Financial statements & key metrics
Stock Price
$7.21
Market Cap
$121.01M
P/E Ratio
-4.5
EPS
$-1.59
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-3.59M
EPS (Diluted)
$-1.59
Balance Sheet Highlights
Total Assets
$1.15M
Total Liabilities
-
Shareholders Equity
-
Cash & Equivalents
$1.04M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-3.16M
CapEx
-
Free Cash Flow
-
Profitability Metrics
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is LIXT revenue?
View LIXT's income statement for detailed revenue data.
Is LIXT profitable?
LIXT reported a loss of $3.59M in the most recent quarter.
What is LIXT market cap?
LIXT has a market capitalization of $121.01M, making it a small-cap stock.
Does LIXT have debt?
View LIXT's balance sheet for debt information.
What is LIXT cash flow?
Cash flow data is available in the full financial statements.